Oncologix Tech, Inc. (OTCPK:OCLG) is looking for acquisitions. Wayne Erwin, Chief Executive Officer of Oncologix said, "With the continued improvement in our revenues, operating margins, along with our acquisition and growth plans, we are confident that our stock values will rise from its current, low levels. The Enterprise Values of the Company remains evident."
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0002 USD | 0.00% | 0.00% | -92.00% |
2022 | DNAGO.Ai entered into a definitive business combination agreement to acquire Oncologix Tech, Inc. in a reverse merger transaction. | CI |
2016 | Oncologix Tech, Inc. Announces Management Changes | CI |
1st Jan change | Capi. | |
---|---|---|
-92.00% | 3L | |
+198.00% | 717.81Cr | |
+2.19% | 98Cr | |
+41.91% | 87Cr | |
+25.43% | 81Cr | |
+1.77% | 66Cr | |
+6.82% | 64Cr | |
-.--% | 60Cr | |
+3.61% | 50Cr | |
-.--% | 50Cr |
- Stock Market
- Equities
- OCLG Stock
- News Oncologix Tech, Inc.
- Oncologix Tech Eyes Acquisitions